Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HRME for Cervical Dysplasia Detection
NCT02420665Phase 1Completed
- Sponsor
- University of Texas MD Anderson Cancer Center
- Start
- Sep 2015
- Primary completion
- May 2021
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial in cervical dysplasia (CIN) and Cervical Cancer (CC), sponsored by University of Texas MD Anderson Cancer Center. Primary endpoint: Concordance Between HRME Diagnosis and Histologic Diagnosis at 1 day. Started Sep 2015; status: completed.
02
Conditions
cervical dysplasia (CIN)Cervical Cancer (CC)
Beyond the preview
Go deeper on NCT02420665.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02420665.